WAC 246-240-151. Use of unsealed radioactive material for uptake, dilution, and excretion studies for which a written directive is not required

Except for quantities that require a written directive under WAC 246-240-060 (2), a licensee may use any unsealed radioactive material prepared for medical use for uptake, dilution, or excretion studies that is: (1) Obtained from a manufacturer, producer, or preparer licensed under WAC 246-235-100 (1) or equivalent NRC or agreement state requirements; or (2) Prepared by an authorized nuclear pharmacist, or a physician who is an authorized user and who meets the requirements specified in WAC 246-240-163 , or 246-240-210 and 246-240-163 (3)(a)(ii)(G), or an individual under the supervision of either as specified in WAC 246-240-057 ; or (3) Obtained from and prepared by an agreement state or NRC licensee for use in research in accordance with a radioactive drug research committee-approved protocol or an investigational new drug protocol accepted by FDA; or (4) Prepared by the licensee for use in research in accordance with a radioactive drug research committee-approved application or an investigational new drug protocol accepted by FDA.